Abstract
KMT2D and KDM1A have opposing effects on histone 3 lysine 4 methylation. In this study, we show that TAK-418, an inhibitor of KDM1A, rescues abnormal gene expression and chromatin levels as well as defects of adult neurogenesis and hippocampal memory in a mouse model of Kabuki syndrome carrying a mutation in Kmt2d.
Original language | English (US) |
---|---|
Pages (from-to) | 779-791 |
Number of pages | 13 |
Journal | Molecular Therapy - Methods and Clinical Development |
Volume | 20 |
DOIs | |
State | Published - Mar 12 2021 |
Keywords
- ERK
- H3K4me1
- H3K4me3
- LSD1
- adult neurogenesis
- chromatin
- epigenetics
- histone modification
- splenomegaly
- therapeutics
ASJC Scopus subject areas
- Molecular Medicine
- Molecular Biology
- Genetics